Skip to main content

Allergan, Inc. Investor Files Lawsuit In Effort To Have The Board Pay The $600 Million Settlement

  • If you are an investor in Allergan, Inc. (NYSE:AGN), and/or have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

An investor of Allergan, Inc. (NYSE:AGN) has filed a lawsuit alleging breaches of fiduciary duty by members of Allergan 's board in effort to have them shoulder the burden of a $600million settlement with the Department of Justice over off-label uses of its Botox drug. Allergan, Inc, located in Irvine, California, is a multi-specialty health care company focused on developing and com...



You must register (for free) or login to view the entire case.